COVID-19 Impact on Global Granisetron Market Size, Status and Forecast 2020-2026

1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered: Ranking by Granisetron Revenue
• 1.4 Market Analysis by Type
  • 1.4.1 Global Granisetron Market Size Growth Rate by Type: 2020 VS 2026
  • 1.4.2 Transdermal system
  • 1.4.3 Injection
  • 1.4.4 Oral
• 1.5 Market by Application
  • 1.5.1 Global Granisetron Market Share by Application: 2020 VS 2026
  • 1.5.2 Chemotherapy
  • 1.5.3 Post operative
• 1.6 Coronavirus Disease 2019 (Covid-19): Granisetron Industry Impact
  • 1.6.1 How the Covid-19 is Affecting the Granisetron Industry
    • 1.6.1.1 Granisetron Business Impact Assessment - Covid-19
    • 1.6.1.2 Supply Chain Challenges
    • 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  • 1.6.2 Market Trends and Granisetron Potential Opportunities in the COVID-19 Landscape
  • 1.6.3 Measures / Proposal against Covid-19
    • 1.6.3.1 Government Measures to Combat Covid-19 Impact
    • 1.6.3.2 Proposal for Granisetron Players to Combat Covid-19 Impact
• 1.7 Study Objectives
• 1.8 Years Considered

2 Global Growth Trends by Regions

• 2.1 Granisetron Market Perspective (2015-2026)
• 2.2 Granisetron Growth Trends by Regions
  • 2.2.1 Granisetron Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 Granisetron Historic Market Share by Regions (2015-2020)
  • 2.2.3 Granisetron Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Porter’s Five Forces Analysis
  • 2.3.5 Granisetron Market Growth Strategy
  • 2.3.6 Primary Interviews with Key Granisetron Players (Opinion Leaders)

3 Competition Landscape by Key Players

• 3.1 Global Top Granisetron Players by Market Size
  • 3.1.1 Global Top Granisetron Players by Revenue (2015-2020)
  • 3.1.2 Global Granisetron Revenue Market Share by Players (2015-2020)
  • 3.1.3 Global Granisetron Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.2 Global Granisetron Market Concentration Ratio
  • 3.2.1 Global Granisetron Market Concentration Ratio (CR5 and HHI)
  • 3.2.2 Global Top 10 and Top 5 Companies by Granisetron Revenue in 2019
• 3.3 Granisetron Key Players Head office and Area Served
• 3.4 Key Players Granisetron Product Solution and Service
• 3.5 Date of Enter into Granisetron Market
• 3.6 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2015-2026)

• 4.1 Global Granisetron Historic Market Size by Type (2015-2020)
• 4.2 Global Granisetron Forecasted Market Size by Type (2021-2026)

5 Granisetron Breakdown Data by Application (2015-2026)

• 5.1 Global Granisetron Market Size by Application (2015-2020)
• 5.2 Global Granisetron Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America Granisetron Market Size (2015-2020)
• 6.2 Granisetron Key Players in North America (2019-2020)
• 6.3 North America Granisetron Market Size by Type (2015-2020)
• 6.4 North America Granisetron Market Size by Application (2015-2020)

7 Europe

• 7.1 Europe Granisetron Market Size (2015-2020)
• 7.2 Granisetron Key Players in Europe (2019-2020)
• 7.3 Europe Granisetron Market Size by Type (2015-2020)
• 7.4 Europe Granisetron Market Size by Application (2015-2020)

8 China

• 8.1 China Granisetron Market Size (2015-2020)
• 8.2 Granisetron Key Players in China (2019-2020)
• 8.3 China Granisetron Market Size by Type (2015-2020)
• 8.4 China Granisetron Market Size by Application (2015-2020)

9 Japan

• 9.1 Japan Granisetron Market Size (2015-2020)
• 9.2 Granisetron Key Players in Japan (2019-2020)
• 9.3 Japan Granisetron Market Size by Type (2015-2020)
• 9.4 Japan Granisetron Market Size by Application (2015-2020)

10 Southeast Asia

• 10.1 Southeast Asia Granisetron Market Size (2015-2020)
• 10.2 Granisetron Key Players in Southeast Asia (2019-2020)
• 10.3 Southeast Asia Granisetron Market Size by Type (2015-2020)
• 10.4 Southeast Asia Granisetron Market Size by Application (2015-2020)

11 India

• 11.1 India Granisetron Market Size (2015-2020)
• 11.2 Granisetron Key Players in India (2019-2020)
• 11.3 India Granisetron Market Size by Type (2015-2020)
• 11.4 India Granisetron Market Size by Application (2015-2020)

12 Central & South America

• 12.1 Central & South America Granisetron Market Size (2015-2020)
• 12.2 Granisetron Key Players in Central & South America (2019-2020)
• 12.3 Central & South America Granisetron Market Size by Type (2015-2020)
• 12.4 Central & South America Granisetron Market Size by Application (2015-2020)

13 Key Players Profiles

• 13.1 Kyowa Kirin
  • 13.1.1 Kyowa Kirin Company Details
  • 13.1.2 Kyowa Kirin Business Overview and Its Total Revenue
  • 13.1.3 Kyowa Kirin Granisetron Introduction
  • 13.1.4 Kyowa Kirin Revenue in Granisetron Business (2015-2020))
  • 13.1.5 Kyowa Kirin Recent Development
• 13.2 Heron Therapeutics
  • 13.2.1 Heron Therapeutics Company Details
  • 13.2.2 Heron Therapeutics Business Overview and Its Total Revenue
  • 13.2.3 Heron Therapeutics Granisetron Introduction
  • 13.2.4 Heron Therapeutics Revenue in Granisetron Business (2015-2020)
  • 13.2.5 Heron Therapeutics Recent Development
• 13.3 Fresenius Kabi
  • 13.3.1 Fresenius Kabi Company Details
  • 13.3.2 Fresenius Kabi Business Overview and Its Total Revenue
  • 13.3.3 Fresenius Kabi Granisetron Introduction
  • 13.3.4 Fresenius Kabi Revenue in Granisetron Business (2015-2020)
  • 13.3.5 Fresenius Kabi Recent Development
• 13.4 Hikma Pharmaceuticals
  • 13.4.1 Hikma Pharmaceuticals Company Details
  • 13.4.2 Hikma Pharmaceuticals Business Overview and Its Total Revenue
  • 13.4.3 Hikma Pharmaceuticals Granisetron Introduction
  • 13.4.4 Hikma Pharmaceuticals Revenue in Granisetron Business (2015-2020)
  • 13.4.5 Hikma Pharmaceuticals Recent Development
• 13.5 Teva
  • 13.5.1 Teva Company Details
  • 13.5.2 Teva Business Overview and Its Total Revenue
  • 13.5.3 Teva Granisetron Introduction
  • 13.5.4 Teva Revenue in Granisetron Business (2015-2020)
  • 13.5.5 Teva Recent Development
• 13.6 Cipla
  • 13.6.1 Cipla Company Details
  • 13.6.2 Cipla Business Overview and Its Total Revenue
  • 13.6.3 Cipla Granisetron Introduction
  • 13.6.4 Cipla Revenue in Granisetron Business (2015-2020)
  • 13.6.5 Cipla Recent Development
• 13.7 Sandoz
  • 13.7.1 Sandoz Company Details
  • 13.7.2 Sandoz Business Overview and Its Total Revenue
  • 13.7.3 Sandoz Granisetron Introduction
  • 13.7.4 Sandoz Revenue in Granisetron Business (2015-2020)
  • 13.7.5 Sandoz Recent Development
• 13.8 Wockhardt
  • 13.8.1 Wockhardt Company Details
  • 13.8.2 Wockhardt Business Overview and Its Total Revenue
  • 13.8.3 Wockhardt Granisetron Introduction
  • 13.8.4 Wockhardt Revenue in Granisetron Business (2015-2020)
  • 13.8.5 Wockhardt Recent Development
• 13.9 Mylan
  • 13.9.1 Mylan Company Details
  • 13.9.2 Mylan Business Overview and Its Total Revenue
  • 13.9.3 Mylan Granisetron Introduction
  • 13.9.4 Mylan Revenue in Granisetron Business (2015-2020)
  • 13.9.5 Mylan Recent Development
• 13.10 APOTEX
  • 13.10.1 APOTEX Company Details
  • 13.10.2 APOTEX Business Overview and Its Total Revenue
  • 13.10.3 APOTEX Granisetron Introduction
  • 13.10.4 APOTEX Revenue in Granisetron Business (2015-2020)
  • 13.10.5 APOTEX Recent Development
• 13.11 Dr.Reddy's
  • 10.11.1 Dr.Reddy's Company Details
  • 10.11.2 Dr.Reddy's Business Overview and Its Total Revenue
  • 10.11.3 Dr.Reddy's Granisetron Introduction
  • 10.11.4 Dr.Reddy's Revenue in Granisetron Business (2015-2020)
  • 10.11.5 Dr.Reddy's Recent Development
• 13.12 Bluepharma
  • 10.12.1 Bluepharma Company Details
  • 10.12.2 Bluepharma Business Overview and Its Total Revenue
  • 10.12.3 Bluepharma Granisetron Introduction
  • 10.12.4 Bluepharma Revenue in Granisetron Business (2015-2020)
  • 10.12.5 Bluepharma Recent Development
• 13.13 Natco Pharma
  • 10.13.1 Natco Pharma Company Details
  • 10.13.2 Natco Pharma Business Overview and Its Total Revenue
  • 10.13.3 Natco Pharma Granisetron Introduction
  • 10.13.4 Natco Pharma Revenue in Granisetron Business (2015-2020)
  • 10.13.5 Natco Pharma Recent Development
• 13.14 Akorn
  • 10.14.1 Akorn Company Details
  • 10.14.2 Akorn Business Overview and Its Total Revenue
  • 10.14.3 Akorn Granisetron Introduction
  • 10.14.4 Akorn Revenue in Granisetron Business (2015-2020)
  • 10.14.5 Akorn Recent Development
• 13.15 Taro Pharmaceutical
  • 10.15.1 Taro Pharmaceutical Company Details
  • 10.15.2 Taro Pharmaceutical Business Overview and Its Total Revenue
  • 10.15.3 Taro Pharmaceutical Granisetron Introduction
  • 10.15.4 Taro Pharmaceutical Revenue in Granisetron Business (2015-2020)
  • 10.15.5 Taro Pharmaceutical Recent Development
• 13.16 Aurobindo
  • 10.16.1 Aurobindo Company Details
  • 10.16.2 Aurobindo Business Overview and Its Total Revenue
  • 10.16.3 Aurobindo Granisetron Introduction
  • 10.16.4 Aurobindo Revenue in Granisetron Business (2015-2020)
  • 10.16.5 Aurobindo Recent Development

14 Analyst's Viewpoints/Conclusions

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Disclaimer